OSA is categorized by severity, and mild sleep apnea can often be minimized through lifestyle changes. Quitting smoking and ...
Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.At the Cardiometabolic Health Congress in ...
Sleep is often a huge challenge for many people, and in several cases, people do need some sort of medical intervention.
Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...
Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.
In a large network meta-analysis of pharmacological, psychological and neurostimulatory ADHD interventions, only stimulants ...
A grant from the Rosenau Family Research Foundation will examine how an enzyme deficiency in the brain leads to this fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback